Neuromuscular junction

LDR 01364nam a22003611i 4500
001 000736241
003 MiAaHDL
005 20210817000000.0
006 m d
007 cr bn ---auaua
008 880718s1976 wb a b 00100 eng
010 ⊔ ⊔ ‡a76001957
020 ⊔ ⊔ ‡a0387074996
035 ⊔ ⊔ ‡a(MiU)990007362410106381
035 ⊔ ⊔ ‡asdr-miu.990007362410106381
035 ⊔ ⊔ ‡a(OCoLC)2326649
035 ⊔ ⊔ ‡a(CaOTULAS)159922161
035 ⊔ ⊔ ‡a(RLIN)MIUG2326649-B
035 ⊔ ⊔ ‡z(MiU)Aleph000736241
040 ⊔ ⊔ ‡aDLC ‡cDLC ‡dMiU
050 0 ⊔ ‡aQP905 ‡b.H3 Bd. 42 ‡aRM312
060 ⊔ ⊔ ‡aQV34 H236 v. 42
082 ⊔ ⊔ ‡a615/.1/08 s ‡a615/.77
245 0 0 ‡aNeuromuscular junction / ‡ccontributors, Ruth E. M. Bowden ... [et al.] ; editor, Eleanor Zaimis, assistant editor, Jennifer Maclagan.
260 ⊔ ⊔ ‡aBerlin ; ‡aNew York : ‡bSpringer-Verlag, ‡c1976.
300 ⊔ ⊔ ‡axv, 746 p. : ‡bill. ; ‡c25 cm.
490 0 ⊔ ‡aHandbook of experimental pharmacology : New series ; v. 42
504 ⊔ ⊔ ‡aIncludes bibliographies and indexes.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 2 ‡aCholinesterase Inhibitors ‡xPharmacodynamics.
650 ⊔ 2 ‡aNeuromuscular Blocking Agents ‡xPharmacodynamics.
650 ⊔ 2 ‡aNeuromuscular Junction ‡xdrug effects.
650 ⊔ 0 ‡aNeuromuscular transmission
650 ⊔ 0 ‡aMyoneural junction
650 ⊔ 0 ‡aNeuromuscular blocking agents.
700 1 ⊔ ‡aZaimis, Eleanor
700 1 ⊔ ‡aBowden, Ruth E. M.
CID ⊔ ⊔ ‡a000736241
DAT 0 ⊔ ‡a19880718000000.0 ‡b20210817000000.0
DAT 1 ⊔ ‡a20210920183725.0 ‡b2024-02-27T18:35:48Z
DAT 2 ⊔ ‡a2024-02-27T18:30:02Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990007362410106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015004364553 ‡sMIU ‡zv.42 ‡1990007362410106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20240227 ‡sgoogle ‡umdp.39015004364553 ‡zv.42 ‡y1976 ‡ric ‡qbib ‡tnon-US bib date1 >= 1929